Scarica l'app Stockscreener
849.15
0.73%
5.52
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché LLY Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Lilly Eli Co Borsa (LLY) Ultime notizie
Guggenheim raises Eli Lilly stock price target to $948 on tirzepatide strength - Investing.com UK
These 2 AI Stocks Could Surpass Oracle in Market Cap by 2030 - The Motley Fool
Puzo Michael J Has $3.57 Million Holdings in Eli Lilly and Company $LLY - MarketBeat
Kidder Stephen W Grows Stock Holdings in Eli Lilly and Company $LLY - MarketBeat
Peter Marks finds a new home at Eli Lilly - FirstWord Pharma
Somerville Kurt F Has $5.65 Million Stock Position in Eli Lilly and Company $LLY - MarketBeat
Eli Lilly Stock Eases After-Hours: Ex-FDA Official Ejected By RFK Jr. Joins Firm — Will Investors Warm Up? - MSN
Major Shareholder Makes a Massive Move with Eli Lilly & Co Stock! - TipRanks
Analysis: Cork operations of Eli Lilly underpin Ozempic maker Novo Nordisk's dwindling market dominance - Irish Examiner
Eli Lilly taps former US FDA official Peter Marks to head infectious disease - Yahoo
Peter Marks, FDA vaccine regulator ousted by RFK Jr., joins Eli Lilly - statnews.com
Former FDA CBER Head Peter Marks Joins Eli Lilly Six Months After Departure - geneonline.com
Former FDA vaccine regulator takes job at Eli Lilly - Washington Examiner
Marks Finds His Next Role as Lilly Snags Another Former FDA Regulator - BioSpace
Peter Marks, former top FDA vaccine official, joins Eli Lilly - BioPharma Dive
Lilly Endowment sells $137 million in Eli Lilly shares - Investing.com
Eli Lilly (LLY) Stock Rises Amid New Executive Appointment - GuruFocus
Former FDA vaccine regulator Peter Marks joins Eli Lilly - StreetInsider
Eli Lilly says Peter Marks named senior VP of molecule discovery & head, infectious disease - MarketScreener
After high-profile FDA exit, Peter Marks lands at Eli Lilly - Fierce Biotech
Former FDA Official Joins Eli Lilly (LLY) for Research Leadershi - GuruFocus
Former FDA vaccine chief Peter Marks joins Eli Lilly - Yahoo
Eli Lilly (LLY) Strengthens Leadership with New Infectious Disea - GuruFocus
Lilly Hires Ex-FDA Official as Infectious Disease Head - Bloomberg.com
How Eli Lilly And Company (LLY) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Former FDA CBER Director Peter Marks lands at Eli Lillyreport - Seeking Alpha
Lilly’s Omvoh benefit continues for four years in UC - Clinical Trials Arena
Eli Lilly (LLY) Reports Promising Long-Term Results for Omvoh in Ulcerative Colitis - GuruFocus
Lilly to spend more than $1B to expand operations in India - dailyjournal.net
Eli Lilly's Mounjaro logs ₹80 crore in September, India's No. 2 drug - Business Standard
Eli Lilly & Co (LLY) Receives a Buy from Bank of America Securities - The Globe and Mail
Eli Lilly to Invest Over $1 Billion in India | - Chemical Industry Digest
Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know - Yahoo Finance
Eli Lilly earmarks $1B to boost India manufacturing footprint - Endpoints News
US pharmaceutical giant Eli Lilly & Co. will invest more than $1 billion in India to expand its contract manufacturing operations and introduce new therapies, including an oral version of its experimental weight-loss drug, orforglipron, ET reported. The investment - instagram.com
Eli Lilly to Invest $1 Billion in India to Boost Contract Manufacturing and Global Medicine Supply - KNN India
Company of the Year 2025: Eli Lilly – Among the heavyweights - PharmaLive
Eli Lilly (LLY) Unveils Promising Long-Term Results for Ulcerati - GuruFocus
Eli Lilly reports final results from LUCENT-3 study of Omvoh - TipRanks
Lilly’s Omvoh shows sustained 4-year efficacy in ulcerative colitis - Investing.com
Eli Lilly strikes AI drug discovery deal with US biotech - Life Sciences Intellectual Property Review
Lilly's Omvoh (mirikizumab-mrkz) is the first and only IL-23p19 antagonist to show four years of sustained, corticosteroid-free comprehensive patient outcomes in ulcerative colitis - Eli Lilly and Company
Eli Lilly’s $1 billion India investment to boost local CMOs and suppliers - Business Today
Eli Lilly to invest more than $1B in India, Reuters reports - The Globe and Mail
Eli Lilly’s Bets $1B India as U.S. Tech Investment Slows Under Tariff Pressure - Tekedia
Eli Lilly's $1 billion India plan to bring fresh jobs for engineers, pharma grads - India Today
Eli Lilly plans major $1bn expansion in Telangana, India - Investment Monitor
Eli Lilly to Invest ₹9,000 Crore in Hyderabad, Boost Telangana’s Pharma Leadership - Analytics India Magazine
Eli Lilly to invest over USD 1 billion in India - medwatch.com
Eli Lilly bets big on India with $1 billion manufacturing push - Healthcare Radius
Eli Lilly To Invest Over USD 1 Bn to Boost Manufacturing in India - Entrepreneur
Eli Lilly plans to invest over USD 1 billion in new contract manufacturing in India - Medical Dialogues
US pharma giant Eli Lilly to invest over $1 billion in Telangana - The News Minute
US pharma major to invest $1 billion in Telangana - The New Indian Express
Major Shareholder Sells Massive Stake in Eli Lilly & Co! - TipRanks
Eli Lilly to Invest $1 Billion in Telangana to Boost Global Pharma Supply - Newsonair
Eli Lilly to invest US$1 billion in India contract manufacturing - The Business Times
Eli Lilly to inject $1 billion in contract manufacturing operations in India - MSN
Eli Lilly Stock Soars on Trump Tariff Hopes and Pfizer Deal - MSN
$1000 Invested In Eli Lilly 10 Years Ago Would Be Worth This Much Today - Benzinga
Eli Lilly to Invest Over $1 Billion in India to Expand Manufacturing Network - Yahoo
Eli Lilly, maker of weight loss drug Mounjaro, to contract manufacture in Telangana, promises $1 billion investment - The Indian Express
Lilly Endowment sells Eli Lilly & Co (LLY) shares worth $161 million - Investing.com
Eli Lilly Stock Rises 16% in a Week: Here's What You Should Know - The Globe and Mail
Eli Lilly to invest $1 billion in India, expand manufacturing and introduce oral weight-loss drug - The Economic Times
US pharma major Eli Lilly to inject $1 billion in new Hyderabad hub - Times of India
Eli Lilly's $1 Billion India Gamble Signals Pharma's Next Global Power Shift - Yahoo Finance
0.11%
0.67%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):